FDA Import Refusal 799-9402778-5/11/1 — BOEHRINGER INGELHEIM
The FDA refused shipment 799-9402778-5/11/1 from BOEHRINGER INGELHEIM (Germany) on Nov 20, 2020. The refused product falls under Drugs and Biologics — LINAGLIPTIN (ANTI-DIABETIC). Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal details
- Date
- Nov 20, 2020
- Country
- Germany
- Product Category
- Drugs and Biologics
- Product Code
- 61PCA66 LINAGLIPTIN (ANTI-DIABETIC)
- Charges
- 75